UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine

Cancer science, 2020-08, Vol.111 (8), p.2708-2717

2020

Volltextzugriff (PDF)

Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy

Cancer science, 2016-11, Vol.107 (11), p.1563-1571

2016

Volltextzugriff (PDF)

MCM10 compensates for Myc‐induced DNA replication stress in breast cancer stem‐like cells

Cancer science, 2021-03, Vol.112 (3), p.1209-1224

2021

Volltextzugriff (PDF)

Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells

Clinical and experimental immunology, 2020-04, Vol.200 (1), p.45-52

2020

Volltextzugriff (PDF)

Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy

Cancer science, 2022-02, Vol.113 (2), p.784-795

2022

Volltextzugriff (PDF)

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure

Cancer science, 2016-07, Vol.107 (7), p.1001-1005

2016

Volltextzugriff (PDF)

LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo

Cancer science, 2022-02, Vol.113 (2), p.709-720

2022

Volltextzugriff (PDF)

Targeting of cancer stem cells by differentiation therapy

Cancer science, 2020-08, Vol.111 (8), p.2689-2695

2020

Volltextzugriff (PDF)

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

Cancer science, 2018-10, Vol.109 (10), p.3183-3196

2018

Volltextzugriff (PDF)

CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells

Cancer science, 2019-01, Vol.110 (1), p.279-288

2019

Volltextzugriff (PDF)

Reverse of non‐small cell lung cancer drug resistance induced by cancer‐associated fibroblasts via a paracrine pathway

Cancer science, 2018-04, Vol.109 (4), p.944-955

2018

Volltextzugriff (PDF)

ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

Cancer science, 2019-03, Vol.110 (3), p.1105-1116

2019

Volltextzugriff (PDF)

HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer

Cancer science, 2021-04, Vol.112 (4), p.1603-1613

2021

Volltextzugriff (PDF)

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy

Cancer science, 2022-02, Vol.113 (2), p.540-552

2022

Volltextzugriff (PDF)

Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial‐mesenchymal transition and 5‐fluorouracil resistance

Cancer science, 2019-01, Vol.110 (1), p.86-98

2019

Volltextzugriff (PDF)

MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma

Cancer science, 2021-09, Vol.112 (9), p.3810-3821

2021

Volltextzugriff (PDF)

Role of inhibitor of yes‐associated protein 1 in triple‐negative breast cancer with taxol‐based chemoresistance

Cancer science, 2019-02, Vol.110 (2), p.561-567

2019

Volltextzugriff (PDF)

Trametinib overcomes KRAS‐G12V–induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR‐mutant lung cancer

Cancer science, 2021-09, Vol.112 (9), p.3784-3795

2021

Volltextzugriff (PDF)

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis

Cancer science, 2019-09, Vol.110 (9), p.2884-2893

2019

Volltextzugriff (PDF)

PAI‐1 induces Src inhibitor resistance via CCL5 in HER2‐positive breast cancer cells

Cancer science, 2018-06, Vol.109 (6), p.1949-1957

2018

Volltextzugriff (PDF)

Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance

Cancer science, 2017-11, Vol.108 (11), p.2195-2203

2017

Volltextzugriff (PDF)

RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia

Cancer science, 2022-02, Vol.113 (2), p.529-539

2022

Volltextzugriff (PDF)

Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib‐resistance of EML4‐ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors

Cancer science, 2017-01, Vol.108 (1), p.53-60

2017

Volltextzugriff (PDF)

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation

Cancer science, 2018-06, Vol.109 (6), p.1853-1864

2018

Volltextzugriff (PDF)

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

Cancer science, 2022-02, Vol.113 (2), p.597-608

2022

Volltextzugriff (PDF)

1 – 25 von 505

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

ThemaMedical Sciences

KollektionIngentaConnect Journals

KollektionWiley Online Library

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(505)
Mit Volltextzugriff
(502)

Publikationsform

Artikel
(505)

Sprache

Englisch
(505)
Japanisch
(183)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(481)
Science & Technology
(481)
Oncology
(338)
Original
(300)
Cell Line, Tumor
(269)
Female
(193)
Drug Resistance
(192)
Drug Resistance, Neoplasm
(176)
Cancer Therapies
(175)
Animals
(171)
Proteins
(170)
Kinases
(168)
Tumors
(154)
Chemotherapy
(146)
Male
(141)
Apoptosis
(134)
Mice
(130)
Drug Resistance, Neoplasm - Genetics
(129)
Gene Expression
(115)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine

Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy

MCM10 compensates for Myc‐induced DNA replication stress in breast cancer stem‐like cells

Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells

Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure

LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo

Targeting of cancer stem cells by differentiation therapy

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells

Reverse of non‐small cell lung cancer drug resistance induced by cancer‐associated fibroblasts via a paracrine pathway

ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy

Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial‐mesenchymal transition and 5‐fluorouracil resistance

MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma

Role of inhibitor of yes‐associated protein 1 in triple‐negative breast cancer with taxol‐based chemoresistance

Trametinib overcomes KRAS‐G12V–induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR‐mutant lung cancer

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis

PAI‐1 induces Src inhibitor resistance via CCL5 in HER2‐positive breast cancer cells

Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance

RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia

Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib‐resistance of EML4‐ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors

Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation

Suppression of multiple anti‐apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms

Aktive Filter

Suchergebnisse filtern